EXAS
NASDAQ · Biotechnology
Exact Sciences Corp
$104.91
+0.99 (+0.95%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+57.57%
YTD
+3.12%
Open$104.93
Previous Close$103.92
Day High$104.98
Day Low$104.90
52W High$104.98
52W Low$64.02
Volume—
Avg Volume4.06M
Market Cap20.03B
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$103.09
Above
SMA 200
$74.54
Above
RSI (14)
73.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
29 analysts
Price Target
+24.6% upside
Current
$104.91
$104.91
Target
$130.71
$130.71
$80.73
$130.71 avg
$205.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.28B | 2.83B | 5.75B |
| Net Income | -210,377,895 | -163,336,875 | -895,146,132 |
| Profit Margin | -6.4% | -6.1% | -15.6% |
| EBITDA | -82,368,262 | -67,503,320 | -1,423,315,581 |
| Free Cash Flow | — | — | -873,819,141 |
| Rev Growth | +15.9% | +15.9% | -4.7% |
| Debt/Equity | 0.97 | 0.97 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |